|
CHEK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.17044218340379E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.9665002959357E-10 |
| Normal-vs-Stage2 |
1.387910E-02 |
| Normal-vs-Stage3 |
2.04309999999319E-05 |
| Normal-vs-Stage4 |
2.24049999997256E-07 |
| Stage1-vs-Stage2 |
6.803800E-01 |
| Stage1-vs-Stage3 |
7.558600E-01 |
| Stage1-vs-Stage4 |
1.535800E-02 |
| Stage2-vs-Stage3 |
5.793600E-01 |
| Stage2-vs-Stage4 |
3.989600E-02 |
| Stage3-vs-Stage4 |
4.419900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.70818914568827E-12 |
| Normal-vs-AfricanAmerican |
2.797400E-03 |
| Normal-vs-Asian |
3.165800E-01 |
| Caucasian-vs-AfricanAmerican |
1.419190E-01 |
| Caucasian-vs-Asian |
9.285400E-01 |
| AfricanAmerican-vs-Asian |
7.097600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.10436137801662E-12 |
| Normal-vs-Female |
1.80100000468641E-08 |
| Male-vs-Female |
6.783600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.754000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.8049996486933E-10 |
| Normal-vs-Age(61-80Yrs) |
2.96009994293911E-10 |
| Normal-vs-Age(81-100Yrs) |
5.596500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.236200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.754200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.700800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.742600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.779800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.105400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.067600E-02 |
| Normal-vs-Grade 2 |
6.93060000500623E-08 |
| Normal-vs-Grade 3 |
3.31800031894147E-10 |
| Normal-vs-Grade 4 |
1.91169999999019E-05 |
| Grade 1-vs-Grade 2 |
3.940200E-01 |
| Grade 1-vs-Grade 3 |
9.222600E-01 |
| Grade 1-vs-Grade 4 |
2.721600E-01 |
| Grade 2-vs-Grade 3 |
6.869600E-02 |
| Grade 2-vs-Grade 4 |
1.092100E-02 |
| Grade 3-vs-Grade 4 |
7.980100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.80320003373424E-09 |
| Normal-vs-ccB subtype |
2.27259999996399E-06 |
| ccA subtype-vs-ccB subtype |
6.655400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.80509998457279E-09 |
| Normal-vs-N1 |
5.317500E-03 |
| N0-vs-N1 |
2.463800E-02 |
|
|
